Evaxion Biotech A/S
EVAXNASDAQHealthcare● Active
$3.73
+$0.18(+5.07%)
Market Cap$23560814
P/E Ratio—
52W High$12.15
52W Low$2.07
Evaxion Biotech A/S（EVAX）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · EVAX · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $7.53M | $3.34M | $0.07M | $0.00M | $0.00M |
| Cost of Revenue | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Gross Profit | $7.53M | $3.34M | $0.07M | $0.00M | $0.00M |
| Gross Margin %(computed) | 100.00% | 100.00% | 100.00% | — | — |
| Operating Expenses | |||||
| R&D Expenses | $9.97M | $10.46M | $11.92M | $17.06M | $19.58M |
| G&A Expenses | $6.49M | $7.32M | $10.08M | $8.06M | $6.18M |
| Total Operating Expenses | $16.76M | $18.08M | $22.27M | $25.26M | $25.83M |
| Operating Income | ($9.23M) | ($14.73M) | ($22.20M) | ($25.26M) | ($25.83M) |
| Operating Margin %(computed) | -122.66% | -440.55% | — | — | — |
| Interest Income | $0.30M | $0.25M | $0.15M | $2.83M | $2.04M |
| Interest Expense | $0.88M | $0.96M | $0.90M | $1.51M | $0.92M |
| Income Before Tax | ($8.62M) | ($11.36M) | ($22.91M) | ($23.94M) | ($24.71M) |
| Income Tax Expense | ($0.91M) | ($0.79M) | ($0.79M) | ($0.77M) | ($0.18M) |
| Net Income | ($7.71M) | ($10.57M) | ($22.13M) | ($23.17M) | ($24.53M) |
| Net Margin %(computed) | -102.38% | -316.00% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.21 | $-9.80 | $-32.40 | $-39.20 | $-50.40 |
| Wtd Avg Shares | 6.41M | 1.07M | 0.68M | 0.59M | 0.49M |
| EBITDA | ($7.12M) | ($9.79M) | ($21.40M) | ($22.57M) | ($24.21M) |
| EBITDA Margin %(computed) | -94.63% | -292.64% | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Evaxion Biotech A/S
关于Evaxion Biotech A/S（EVAX）损益表
Evaxion Biotech A/S（EVAX）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，EVAX实现营收$0.01B，毛利润$0.01B（毛利率100.00%），净利润($0.01B)（净利率-102.38%）。
常见问题
EVAX · 4 问Evaxion Biotech A/S（EVAX）2025财年营收为$0.01B，同比up125.1%。
EVAX revenueEVAX salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09